# A Study of JNJ-64417184, Administered as an Oral Solution, in Healthy Participants

> **NCT04258189** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-64417184

## Key facts

- **NCT ID:** NCT04258189
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-11
- **Primary completion:** 2020-08-05
- **Final completion:** 2020-08-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04258189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04258189, "A Study of JNJ-64417184, Administered as an Oral Solution, in Healthy Participants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04258189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*